Piros Tablet 30 mg (Pioglitazone Hydrochloride)
Pioglitazone Hydrochloride
Prescription medication
IYON Pharmaceutical Co., Ltd.
MFDS item code 201902391 · Approved 2019.04.17
This product's status changed to Approval withdrawn on 2023.05.26. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Improvement of glycemic control in type 2 diabetes mellitus
This medication is used as an adjunct to diet and exercise to help control blood sugar levels in patients with type 2 diabetes. It can be used alone but may also be combined with sulfonylureas, metformin, or insulin when other oral hypoglycemic agents do not effectively improve blood sugar levels. Nutritional counseling, weight loss, and regular exercise are also very important in treating type 2 diabetes, as these lifestyle changes greatly enhance the effectiveness of medication therapy. Therefore, this medication is effectively used to improve blood sugar control.
This medicine is administered orally once daily, with or without food. For monotherapy, the starting dose is 15 mg once daily; if the effect is insufficient, the dose may be increased to 30 mg once daily. For combination therapy, 15 mg is also administered once daily, and the maximum recommended dose should not exceed 30 mg once daily.
Use is not recommended in children under 18 years of age because there is no experience with its use in this population.
This medication is used to treat type 2 diabetes and acts to improve insulin resistance. Some patients taking this medication may experience heart-related issues, so if symptoms of heart failure such as sudden weight gain, shortness of breath, or leg swelling occur, they should seek medical attention immediately. This medication should not be taken by patients with heart failure or a history of heart failure. Additionally, this medication can cause fluid retention, which may worsen heart failure; therefore, caution is needed when prescribed to patients with cardiovascular conditions. Patients taking this medication should inform their doctor immediately if they experience symptoms such as hematuria, urinary difficulties, or urgency, as these may indicate a potential risk for bladder cancer. This medication is not administered to patients with impaired liver function, severe kidney disease, or active bladder cancer, or those with a history of bladder cancer. Women who are pregnant or may become pregnant should not take this medication, and premenopausal women should use effective contraception as this medication may stimulate ovulation and increase the risk of pregnancy. When taken with other hypoglycemic agents or insulin, there may be an increased risk of hypoglycemia; therefore, patients should be well-informed about hypoglycemic symptoms and dose adjustments of other medications may be necessary. Regular liver function tests and blood glucose monitoring are recommended while taking this medication, and if symptoms such as sudden weight gain, swelling, or shortness of breath occur, immediate consultation with healthcare professionals is needed. Common side effects of this medication may include edema, weight gain, headache, and upper respiratory infections, and there may be an increased risk of fractures, especially in women, so attention to bone health is necessary. Overdosage may not present with specific symptoms, but appropriate treatment should be given depending on the symptoms. The safety and efficacy of this medication in children have not been established, and caution is warranted in the elderly as well. There may be drug interactions, so any concurrent medications should be discussed with a doctor or pharmacist. Store this medication in its original container, out of reach of children.
Congestive heart failure, excessive and rapid weight changes, shortness of breath, edema, fluid retention, inadequate blood sugar control, upper respiratory tract infections, headache, sinusitis, myalgia, pharyngitis, abdominal bloating, weight gain, hypoglycemia, urinary tract infection, low back pain, dizziness, diarrhea, elevated blood creatine kinase, hypertension, heart failure, limb pain, chest pain, deaths due to cardiovascular predisposition, worsening of congestive heart failure, emergency room visits due to congestive heart failure, adverse cardiovascular events, dizziness, increased blood sugar, elevated ALT/AST, loss of appetite, constipation, upper abdominal pain, chest pain, fatigue, weakness, indigestion, nausea, shortness of breath, itching, chest discomfort, tremors, chills, gastrointestinal diseases, abdominal pain, epigastric discomfort, tingling sensation, muscle stiffness, head discomfort, increased liver enzymes, worsening of liver disease, hives, eczema, arthralgia, knee abnormalities, arm weakness, proteinuria, increased blood creatinine, anxiety, insomnia, drowsiness, simple herpes, blurred vision, orthostatic hypotension, palpitations, stroke, sexual dysfunction, myocardial infarction, abdominal pain, heart failure, edema-related adverse reactions, liver failure, diabetic macular edema with decreased vision, fractures, bladder cancer
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a container that blocks light and air, and care should be taken to avoid moisture. The recommended storage temperature is between 15°C and 30°C, preferably around 25°C in a cool place.
White round tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Pioglitazone Hydrochloride
Prescription medication
IYON Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 33.06mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Dongwha Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Hanol Bio Pharma Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Kujoo Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Kyungdong Pharm Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.